0002138549-26-000001.txt : 20260708 0002138549-26-000001.hdr.sgml : 20260708 20260708162423 ACCESSION NUMBER: 0002138549-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260708 DATE AS OF CHANGE: 20260708 EFFECTIVENESS DATE: 20260708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harbright 2026 VQ Biomedical Series, a series of Harbright LLC CENTRAL INDEX KEY: 0002138549 ORGANIZATION NAME: EIN: 422640938 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590029 FILM NUMBER: 261162629 BUSINESS ADDRESS: STREET 1: 107 KILMAYNE DRIVE STREET 2: SUITE B CITY: CARY STATE: NC ZIP: 27511 BUSINESS PHONE: 9193356001 MAIL ADDRESS: STREET 1: 107 KILMAYNE DRIVE STREET 2: SUITE B CITY: CARY STATE: NC ZIP: 27511 D 1 primary_doc.xml X0708 D LIVE 0002138549 Harbright 2026 VQ Biomedical Series, a series of Harbright LLC 107 KILMAYNE DRIVE SUITE B CARY NC NORTH CAROLINA 27511 9193356001 DELAWARE None None Limited Liability Company true 2026 John Michael Harlow 744 Parkridge Drive Clayton NC NORTH CAROLINA 27527 Director Promoter Robert Earl Ross 107 Kilmayne Drive Suite B Cary NC NORTH CAROLINA 27511 Director Promoter John Powell Leachman 155 Piedmont Ave. Gainesville GA GEORGIA 30501 Director Promoter Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2026-06-29 false true false 10000 1000000 597000 403000 false 15 0 0 0 false Harbright 2026 VQ Biomedical Series, a series of Harbright LLC John Michael Harlow John Michael Harlow Managing Partner 2026-07-08